Key facts
- Charta Health’s last known valuation is $125.0M (Jun 2025).
- It has raised $30.1M across 1 recorded rounds; the latest was Early Stage VC ($30.1M) in Jun 2025.
- Notable investors include SV Angel, Bain Capital Ventures, South Park Commons, Madrona Venture Group, Refract Ventures — 6 tracked in total.
- Charta Health has filed 1 Form D with the SEC, most recently Jul 2025 ($30.1M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Charta Health
Funding rounds
1 roundsAbout Charta Health
Developer of an automated pre-bill review platform designed to help physicians with clinical accuracy and capture every revenue and quality opportunity. The company's platform offers various features such as real-time dashboards and downloadable spreadsheets, clinical and billing audits, reporting and analytics, autonomous chart reviews, and more, enabling health professionals to transform healthcare administration and improve patient care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 29
- Website
- chartahealth.com/
- Ownership
- Privately Held (backing)
Charta Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Charta Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Charta Health in its N-PORT filings yet. We sweep new filings monthly.